Recurrent or Refractory Pediatric Ependymoma
1 clinical trials · Condition
◉ Watch Recurrent or Refractory Pediatric Ependymoma
| Record | Firm | Date |
|---|---|---|
| Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma (NCT01032070) | OSI Pharmaceuticals | 2010-09-27 |
Track Recurrent or Refractory Pediatric Ependymoma automatically
Every clearance here is in the API, with alerts when new ones post.